These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31659740)

  • 1. Vitamin D binding protein and risk of renal cell carcinoma in the prostate, lung, colorectal and ovarian cancer screening trial.
    Kratzer TB; Weinstein SJ; Albanes D; Mondul AM
    Int J Cancer; 2020 Aug; 147(3):669-674. PubMed ID: 31659740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D-binding protein, circulating vitamin D and risk of renal cell carcinoma.
    Mondul AM; Weinstein SJ; Moy KA; Männistö S; Albanes D
    Int J Cancer; 2014 Jun; 134(11):2699-706. PubMed ID: 24214881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D-Binding Protein and Risk of Renal Cell Carcinoma in the Cancer Prevention Study-II Cohort.
    Mondul AM; Weinstein SJ; Parisi D; Um CY; McCullough ML; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2018 Oct; 27(10):1203-1207. PubMed ID: 30030213
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal-cell carcinoma risk estimates based on participants in the prostate, lung, colorectal, and ovarian cancer screening trial and national lung screening trial.
    Lotan Y; Karam JA; Shariat SF; Gupta A; Roupret M; Bensalah K; Margulis V
    Urol Oncol; 2016 Apr; 34(4):167.e9-16. PubMed ID: 26602092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial.
    Liao LM; Hofmann JN; Cho E; Pollak MN; Chow WH; Purdue MP
    Cancer Causes Control; 2017 Jul; 28(7):801-807. PubMed ID: 28484923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum vitamin D and risk of bladder cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening trial.
    Mondul AM; Weinstein SJ; Horst RL; Purdue M; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2012 Jul; 21(7):1222-5. PubMed ID: 22623707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Weinstein SJ; Purdue MP; Smith-Warner SA; Mondul AM; Black A; Ahn J; Huang WY; Horst RL; Kopp W; Rager H; Ziegler RG; Albanes D
    Int J Cancer; 2015 Mar; 136(6):E654-64. PubMed ID: 25156182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum vitamin D concentration and prostate cancer risk: a nested case-control study.
    Ahn J; Peters U; Albanes D; Purdue MP; Abnet CC; Chatterjee N; Horst RL; Hollis BW; Huang WY; Shikany JM; Hayes RB;
    J Natl Cancer Inst; 2008 Jun; 100(11):796-804. PubMed ID: 18505967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum 25-hydroxyvitamin D, vitamin D binding protein, and prostate cancer risk in black men.
    Layne TM; Weinstein SJ; Graubard BI; Ma X; Mayne ST; Albanes D
    Cancer; 2017 Jul; 123(14):2698-2704. PubMed ID: 28369777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LINE1 methylation levels in pre-diagnostic leukocyte DNA and future renal cell carcinoma risk.
    Karami S; Andreotti G; Liao LM; Pfeiffer RM; Weinstein SJ; Purdue MP; Hofmann JN; Albanes D; Mannisto S; Moore LE
    Epigenetics; 2015; 10(4):282-92. PubMed ID: 25647181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of one-carbon metabolism biomarkers and risk of renal cell carcinoma.
    Gibson TM; Weinstein SJ; Mayne ST; Pfeiffer RM; Selhub J; Taylor PR; Virtamo J; Albanes D; Stolzenberg-Solomon R
    Cancer Causes Control; 2010 Jul; 21(7):1061-9. PubMed ID: 20383577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nested case-control study of leukocyte mitochondrial DNA copy number and renal cell carcinoma in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
    Hofmann JN; Hosgood HD; Liu CS; Chow WH; Shuch B; Cheng WL; Lin TT; Moore LE; Lan Q; Rothman N; Purdue MP
    Carcinogenesis; 2014 May; 35(5):1028-31. PubMed ID: 24398668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating biomarkers of one-carbon metabolism in relation to renal cell carcinoma incidence and survival.
    Johansson M; Fanidi A; Muller DC; Bassett JK; Midttun Ø; Vollset SE; Travis RC; Palli D; Mattiello A; Sieri S; Trichopoulou A; Lagiou P; Trichopoulos D; Ljungberg B; Hallmans G; Weiderpass E; Skeie G; González CA; Dorronsoro M; Peeters PH; Bueno-de-Mesquita HB; Ros MM; Boutron Ruault MC; Fagherazzi G; Clavel F; Sánchez MJ; Gurrea AB; Navarro C; Quiros JR; Overvad K; Tjønneland A; Aleksandrova K; Vineis P; Gunter MJ; Kaaks R; Giles G; Relton C; Riboli E; Boeing H; Ueland PM; Severi G; Brennan P
    J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating levels of adipocytokine omentin-1 in patients with renal cell cancer.
    Shen XD; Zhang L; Che H; Zhang YY; Yang C; Zhou J; Liang CZ
    Cytokine; 2016 Jan; 77():50-5. PubMed ID: 26539805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum vitamin D, vitamin D binding protein, and risk of colorectal cancer.
    Anic GM; Weinstein SJ; Mondul AM; Männistö S; Albanes D
    PLoS One; 2014; 9(7):e102966. PubMed ID: 25036524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating 25-hydroxyvitamin D3 in relation to renal cell carcinoma incidence and survival in the EPIC cohort.
    Muller DC; Fanidi A; Midttun Ø; Steffen A; Dossus L; Boutron-Ruault MC; Severi G; Kühn T; Katzke V; de la Torre RA; González CA; Sánchez MJ; Dorronsoro M; Santiuste C; Barricarte A; Khaw KT; Wareham N; Travis RC; Trichopoulou A; Giotaki M; Trichopoulos D; Palli D; Krogh V; Tumino R; Vineis P; Panico S; Tjønneland A; Olsen A; Bueno-de-Mesquita HB; Peeters PH; Ljungberg B; Wennberg M; Weiderpass E; Murphy N; Riboli E; Ueland PM; Boeing H; Brennan P; Johansson M
    Am J Epidemiol; 2014 Oct; 180(8):810-20. PubMed ID: 25205830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIM-1 as a Blood-Based Marker for Early Detection of Kidney Cancer: A Prospective Nested Case-Control Study.
    Scelo G; Muller DC; Riboli E; Johansson M; Cross AJ; Vineis P; Tsilidis KK; Brennan P; Boeing H; Peeters PHM; Vermeulen RCH; Overvad K; Bueno-de-Mesquita HB; Severi G; Perduca V; Kvaskoff M; Trichopoulou A; La Vecchia C; Karakatsani A; Palli D; Sieri S; Panico S; Weiderpass E; Sandanger TM; Nøst TH; Agudo A; Quirós JR; Rodríguez-Barranco M; Chirlaque MD; Key TJ; Khanna P; Bonventre JV; Sabbisetti VS; Bhatt RS
    Clin Cancer Res; 2018 Nov; 24(22):5594-5601. PubMed ID: 30037816
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediagnostic circulating adipokine concentrations and risk of renal cell carcinoma in male smokers.
    Liao LM; Weinstein SJ; Pollak M; Li Z; Virtamo J; Albanes D; Chow WH; Purdue MP
    Carcinogenesis; 2013 Jan; 34(1):109-12. PubMed ID: 23042303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A higher circulating concentration of 25-hydroxyvitamin-D decreases the risk of renal cell carcinoma: a case-control study.
    Li F; Zhao H; Hou L; Ling F; Zhang Y; Tan W
    Int Braz J Urol; 2019; 45(3):523-530. PubMed ID: 30785699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead, calcium uptake, and related genetic variants in association with renal cell carcinoma risk in a cohort of male Finnish smokers.
    Southard EB; Roff A; Fortugno T; Richie JP; Kaag M; Chinchilli VM; Virtamo J; Albanes D; Weinstein S; Wilson RT
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):191-201. PubMed ID: 22086884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.